Fabrizio Vianello

Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy

Yuhui Huang, Jian‐Ping Yuan, Elda Righi et al. · Proceedings of the National Academy of Sciences · 2012 · 1.1K citations · Full text

Medicine, Immunology, Oncology +14

CXCL12/CXCR4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer

Elda Righi, Satoshi Kashiwagi, J. P. Yuan et al. · Cancer Research · 2011 · 250 citations · Full text

Medicine, Immunology, Oncology +17

<i>MYH9</i>-Related Disease: A Novel Prognostic Model to Predict the Clinical Evolution of the Disease Based on Genotype-Phenotype Correlations

Alessandro Pecci, Catherine Klersy, Paolo Gresele et al. · Human Mutation · 2013 · 200 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axis

Fabrizio Vianello, Federica Villanova, Veronica Tisato et al. · Haematologica · 2010 · 169 citations · Full text

Medicine, Oncology, Pharmacology +17

Murine B16 Melanomas Expressing High Levels of the Chemokine Stromal-Derived Factor-1/CXCL12 Induce Tumor-Specific T Cell Chemorepulsion and Escape from Immune Control

Fabrizio Vianello, Natalia Papeta, Tao Chen et al. · The Journal of Immunology · 2006 · 119 citations

Medicine, Immunology, Oncology +17